Just – Evotec生物制药公司与BARDA合作，提升针对埃博拉病毒和其他病毒威胁的抗体生产能力

by GOAI

由GOAI生成

Share To

分享到

Just – Evotec Biologics has entered into a project agreement with the Biomedical Advanced Research and Development Authority (BARDA) to enhance biomanufacturing processes for antibodies targeting Ebola and related viruses. The collaboration aims to optimize the production of monoclonal antibodies, which are critical in combating viral threats such as Ebola.

Just – Evotec Biologics 与生物医学高级研究与发展管理局 (BARDA) 签订了一项项目协议，以改进针对埃博拉病毒及相关病毒的抗体生物制造工艺。此次合作旨在优化单克隆抗体的生产，这些抗体对抗埃博拉等病毒威胁至关重要。

This initiative focuses on improving efficiency and scalability in antibody manufacturing..

该计划的重点是提高抗体生产的效率和可扩展性。

The agreement outlines efforts to develop advanced biomanufacturing technologies that can respond rapidly to public health emergencies involving viral outbreaks. BARDA’s involvement highlights the importance of preparedness against infectious diseases, while Just – Evotec Biologics brings its expertise in biologics development and manufacturing to the partnership.

该协议概述了开发先进生物制造技术的努力，这些技术能够对涉及病毒爆发的公共卫生紧急情况做出快速反应。BARDA 的参与突显了应对传染病准备的重要性，而 Just – Evotec Biologics 则将其在生物制品开发和制造方面的专业知识带入了合作。

Both parties aim to address challenges in producing high-quality therapeutic antibodies at scale, ensuring readiness for potential future outbreaks..

双方都旨在应对大规模生产高质量治疗性抗体的挑战，确保为潜在的未来疫情做好准备。

Newsflash | Powered by GeneOnline AI

新闻快讯 | 由GeneOnline AI提供支持

Source: GO-AI-ne1

来源：GO-AI-ne1

For any suggestion and feedback, please contact us.

如有任何建议和反馈，请联系我们。

Date: March 23, 2026

日期：2026年3月23日

©www.geneonline.com All rights reserved. Collaborate with us:

©www.geneonline.com 版权所有。与我们合作：

[email protected]

电子邮件地址

Author

作者

GOAI

GOAI

Related Post

相关文章